|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 541.69 USD | -1.07% |
|
-1.16% | +19.48% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 137B | AA | |||||||
| 1,047B | A | |||||||
| 646B | - | BBB | - | - | ||||
| 451B | AA | - | ||||||
| 355B | AA | |||||||
| 291B | AAA | |||||||
| 252B | A | |||||||
| 234B | A | |||||||
| 203B | A | |||||||
| 181B | AA | |||||||
| 159B | A | |||||||
| 136B | A | |||||||
| 107B | AA | |||||||
| 101B | AA | |||||||
| 72.33B | AA | |||||||
| 57.89B | AA | |||||||
| 55.49B | AA | |||||||
| 46.32B | AA | |||||||
| 43.98B | AA | |||||||
| 42.46B | - | |||||||
| Average | 230.93B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
